During the past decade, Darst Dermatology conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Darst Dermatology" are "Alopecia Areata" (3 trials), "Cutaneous Common Warts" (1 trials), "Plaque Psoriasis" (1 trials) and "Scalp Psoriasis" (1 trials). Many other conditions were trialed in "Darst Dermatology" in a lesser frequency.

Most popular intervention types in "Darst Dermatology" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "CTP-543" (2 trials), "Placebo" (2 trials), "CLS006" (1 trials), "CLS006 Vehicle" (1 trials) and "CTP-543, 12 mg BID" (1 trials). Other intervention names were less common.

The vast majority of trials in "Darst Dermatology" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Darst Dermatology". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 2 completed trials in Darst Dermatology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Darst Dermatology, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".